GILD - CIK 0000882095
The table below shows GILEAD SCIENCES, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | - | - | - | - | - | - |
| Short-term investments | $15.00M | $19.00M | $69.00M | - | $0.00 | $0.00 |
| Receivables | $4.74B | $5.09B | $4.78B | $4.39B | $4.59B | $4.66B |
| Inventory | $1.91B | $1.78B | $1.82B | $1.76B | $1.87B | $2.03B |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $18.64B |
| $17.87B |
| $14.72B |
| $16.90B |
| $14.78B |
| $12.32B |
| Property, plant & equipment | $5.64B | $5.50B | $5.46B | $5.42B | $5.39B | $5.35B |
| Goodwill | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B |
| Total assets | $56.28B | $58.53B | $55.72B | $56.43B | $54.52B | $53.58B |
| Accounts payable | $645.00M | $808.00M | $582.00M | $737.00M | $903.00M | $537.00M |
| Total current liabilities | $9.48B | $12.30B | $11.19B | $12.34B | $11.72B | $10.78B |
| Long-term debt | $20.86B | $22.14B | $22.14B | $22.15B | $21.44B | $21.54B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $14.13B | $12.82B | $11.32B | $10.93B | $11.07B | $11.16B |
| Total equity | $23.52B | $21.54B | $19.67B | $19.16B | $18.48B | $18.28B |